We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TMUS:NASDAQT-Mobile US, Inc. Analysis

Data as of 2026-03-09 - not real-time

$217.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

T‑Mobile is trading around $217.5, which sits well above the DCF‑derived fair value of roughly $54, indicating a substantial premium and a overvalued status. The stock’s forward price‑to‑earnings multiple of 15.5 is lower than its trailing PE of 22.4, reflecting analyst optimism about earnings acceleration. Revenue is expanding at an 11 % annual rate and margins remain healthy, supporting the company’s growth narrative. A dividend yield of 1.84 % coupled with a modest 38 % payout ratio suggests the distribution is financially sustainable. Technical gauges are mixed: the price is above the 20‑day and 50‑day SMAs but below the 200‑day SMA, and the MACD has turned bearish with a negative histogram. Volume trends are declining, and the 30‑day volatility of nearly 30 % adds a short‑term risk element. The beta of roughly 0.2 underscores the stock’s relative insulation from broader market swings. Recent analyst activity has been positive, highlighted by Daiwa Capital’s upgrade to Outperform and an average price target of $267, implying a 25 % upside from current levels. The company also announced a euro‑denominated debt offering, which could diversify its funding base but introduces modest currency exposure. Fourth‑quarter results beat expectations, reinforcing the earnings momentum that underpins the forward EPS outlook. Despite these positives, the gap between market price and intrinsic value, combined with bearish technical signals, tempers enthusiasm. Consequently, investors should weigh the strong cash flow and growth prospects against the current overvaluation and volatility before adjusting positions.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD signal
  • Price below 200‑day SMA
  • Decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue growth
  • Improving forward PE
  • Analyst price target upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend
  • Robust cash flow generation
  • Long‑term market share expansion

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin12.45%
P/E Ratio22.4
ROE18.18%
ROA5.68%
Debt/Equity208.85
P/B Ratio4.1
Op. Cash Flow$28.0B
Free Cash Flow$8.0B
Industry P/E18.3

Technical Analysis

TrendNeutral
RSI57.7
Support$188.15
Resistance$224.75
MA 20$215.46
MA 50$202.96
MA 200$222.79
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$53.86
Target Price$268.52
Upside/Downside23.46%
GradeOvervalued
TypeGrowth
Dividend Yield1.84%

Risk Assessment

Beta0.19
Volatility29.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.